Publication: 3325

Tolerability and Toxicity of Trastuzumab or Trastuzumab + Lapatinib in Older Patients: A Sub-analysis of the ALTTO Trial (BIG 2–06; NCCTG (Alliance) N063D)
      QxMD      Google Scholar   
Citation:
Breast Cancer Res Treat vol 185 (1) 107-116
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3088  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
GSK, Novartis  
Grants:
U10CA180821, UG1CA233180, UG1CA232760  
Corr. Author:
 
Authors:
                             
Networks:
LAPS-MN026   
Study
NCCTG-N063D
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
breast cancer, geriatric oncology, anti-HER2